Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Single-center experience with...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases

Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases

Bibliographic Details
Main Authors: Anil Kapoor, Nathan C Wong, Yuding Wang, Som Mukherjee, Sebastien Hotte, Ian Dayes, Himu Lukka
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Asian Journal of Andrology
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2020;volume=22;issue=4;spage=437;epage=438;aulast=Kapoor
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.ajandrology.com/article.asp?issn=1008-682X;year=2020;volume=22;issue=4;spage=437;epage=438;aulast=Kapoor

Similar Items

  • Radium-223 for the treatment of patients with castration-resistant prostate cancer with bone metastases
    by: A. D. Kaprin, et al.
    Published: (2018-07-01)
  • Radium-223 in metastatic castration resistant prostate cancer
    by: Winston Vuong, et al.
    Published: (2014-06-01)
  • Clinical experience with radium-223 in the treatment of patients with advanced castrate-resistant prostate cancer and symptomatic bone metastases
    by: Christina Hague, et al.
    Published: (2016-06-01)
  • Intravenous radionuclide therapy with radium chloride [223Ra] in patients with bone metastases from castration-resistant prostate cancer
    by: O. I. Kit, et al.
    Published: (2024-12-01)
  • Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program
    by: Axel Heidenreich, et al.
    Published: (2019-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs